Tag: life sciences
-
Crispr Heart Disease Biotech Raises $94M in New Funds
A company applying Crispr gene-editing technology to treat inherited heart disease is raising $94 million in its second venture funding round.
-
Multi-Variant Covid-19 Vaccine in the Works
A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon.
-
Registry Tracking Long-Term Covid-19 Impacts
A study now underway is tracking long-term effects of Covid-19 infections using real-world data from electronic sources provided by patients.
-
Micro-Robot Designed to Aid Internal Laser Surgery
An engineering team demonstrated a small robotic device that fits on current surgical equipment to improve laser surgery inside the body.
-
Biotech Licenses mRNA Technology for Aging
A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging.
-
US Govt to Buy 1.25M Regeneron Covid-19 Therapies
The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion.
-
Drug Maker Gains Access to Hidden Protein Immunotherapies
Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells.
-
Moderna Developing Flu, HIV, Nipah Vaccines
Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases.
-
Drug Price Disruptor Biotech Raises $500M in New Funds
A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round.
-
Digital Therapeutics Designed for Cancer/Covid-19 Stress
A digital health company is partnering with cancer advocacy organizations to provide electronic therapies to help patients deal with stresses from Covid-19.